| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |